← Ticker index
BSX
Ticker
BSX
Congressional Trades
140
by 11 members
Ticker disclosure brief
Congressional disclosure records for BSX
A ticker-first view of recent disclosures, reported ranges, filing lags, party aggregates, federal awards, lobbying records, and source-linked receipts.
Latest receipt
Ro Khanna
BUY · 2026-06-30
Largest range
$100K – $250K
Michael McCaul
Longest observed gap
318d
Valerie Hoyle
Highest 30d vs SPY
4.4%
Ro Khanna
Purchase rows
50
36%
Sale rows
75
54%
Disclosed midpoint
$2.3M
range estimate
Unique Traders
11
members
Disclosure timing method
Observed filing gaps are not notice-date findings
The reporting deadline is the earlier of 30 days after notice or 45 days after the transaction. Public disclosure rows provide transaction and filing dates, but do not establish when a member received notice. PoliWealth therefore marks only transaction-to-filing gaps over 45 days as an apparent delay for review; 31–45 day gaps are not labeled late from transaction date alone.
Party Breakdown
Democrats99 · 71%
Republicans41 · 29%
Federal awards
all →- 2026-07-09$17KDepartment of Health and Human ServicesINTERVENTIONAL RADIOLOGY CONSUMABLES TO TREAT CC/NIH PATIENTS
- 2026-07-08$15KDepartment of Veterans AffairsPROSTHETICS - NEUROSTIMULATOR
- 2026-07-02$52KDepartment of Veterans AffairsSURGERY DILATION CATHETERS
- 2026-07-01$25KDepartment of Veterans AffairsRF PAIN GENERATOR
- 2026-06-30$32KDepartment of Veterans AffairsIMPLANTABLE CARDIOVERTER DEFIBRILLATOR
- 2026-06-29$125KDepartment of Veterans AffairsWATCHMAN FLX PRO
- 2026-06-29$23KDepartment of Veterans AffairsEMERGENCY PROCUREMENT. EO 14398.
- 2026-06-12$305KDepartment of Veterans AffairsY-90 THERASPHERE
- 2026-05-19$28KDepartment of Veterans AffairsBOSTON SCIENTIFIC POLARIS ILAB SERVICE AGREEMENT
- 2026-05-08$28KDepartment of Veterans AffairsPROSTHETICS:IMPLANT
Lobbying filings
all →- 2026-07-10$20KBOSTON SCIENTIFIC CORPORATIONMedical Supply Chain program reforms, MSPV, PSAS, IT HR 6549, VA Contracting and Procurement Act HR 9237, Taking Care of Veterans Act S2918, Veterans Prosthetics Advancement and Reform Act
- 2026-04-20$642KBOSTON SCIENTIFIC CORPORATIONMedical device procurement and supply chain resiliency. Ensuring VHA patient access to Med Tech as VHA manages supply chain and upgrades its medical surgery and prosthetics procurement contracting. Pain management - working to increase veteran access to multidisciplinary and multimodal pain management to provide for effective non-opioid treatment alternatives. VA Authorization Bill of 2025- Specifically, H.R. 6549 The VA Contracting and Procurement Act. This bill would reform VAs contracting process by modernizing medical implant acquisition and consolidating billing for surgical procedures to enhance delivery of care to veterans. FY2027 Appropriations: Advocacy efforts on including report language in Labor-HHS to advance non-opioid, evidence-based pain management and in VA/DoD accounts to support modernization of procurement processes, including a transparent product add cycle and a streamlined single purchase order mechanism. OECD 2 Pillar Framework Implementation - International t
- 2026-04-20$80KBOSTON SCIENTIFIC CORPORATIONIssues concerning Medicare reimbursement, AI and medical technology. Advocacy concerning tax issues. Advocacy concerning trade issues.
- 2026-04-20$60KBOSTON SCIENTIFICInterntational tax reform, TCJA reauthorization
- 2026-04-17$0BOSTON SCIENTIFIC (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024.
- 2026-04-15$20KBOSTON SCIENTIFIC CORPORATIONMedical Supply Chain program reforms HR 6549, VA Contracting and Procurement Act
- 2026-01-21$60KBOSTON SCIENTIFICInterntational tax reform, TCJA reauthorization
- 2026-01-20$80KBOSTON SCIENTIFIC CORPORATIONIssues concerning Medicare reimbursement, AI and medical technology. Advocacy concerning tax issues. Advocacy concerning trade issues.
- 2026-01-20$0BOSTON SCIENTIFIC (OFFICE-BASED FACILITY ASSN OBFA) (FKA USPA)Medicare Physician Fee Schedule; Medicare Physician Fee Schedule reform; H.R.10136 - Promoting Fairness for Medicare Providers Act of 2024.
- 2026-01-16$570KBOSTON SCIENTIFIC CORPORATIONEnsuring Patient Access to Critical Breakthrough Products Act of 2025(H.R. 5343 and S.1717) - Legislation to create automatic CMS coverage for devices approved via FDA's breakthrough pathway. (CMS rulemaking for Transitional Coverage of Emerging Technologies (TCET) - advocacy for a new, voluntary Transitional Coverage of Emerging Technologies (TCET) pathway that provides national Medicare coverage for Breakthrough-designated technologies, beginning on the date of FDA market authorization.) The Patient Access to Innovative New Technologies Act (PAINT Act) -- proposed legislation that aims to expand access to new medical technologies by improving the Medicare New Technology Add-on Payment (NTAP) program. It would create a single deadline for products in an alternative pathway, ensure breakthrough devices are eligible for conditional approval under NTAP, and prevent disruption in Medicare beneficiaries' access to new treatments. 2025 Reauthorization of the SUPPORT for Patients and Communi
Loading trade analytics…
All Disclosed Trades
Page 4 · 25 of 140 shown| Date | Member | Action | Amount | Observed Gap | Receipt |
|---|---|---|---|---|---|
| 2025-07-31 | DGilbert Cisneros | SELL | $1K – $15K | 15d | receipt → |
| 2025-07-31 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-07-31 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-07-31 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 13d | receipt → |
| 2025-07-31 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 13d | receipt → |
| 2024-12-11 | RLisa McClain | BUY | $1K – $15K | 245dApparent delay | receipt → |
| 2024-12-11 | RLisa McClain | BUY | $1K – $15K | 245dApparent delay | receipt → |
| 2025-06-26 | DGilbert Cisneros | SELL | $1K – $15K | 15d | receipt → |
| 2025-06-11 | DGilbert Cisneros | SELL | $1K – $15K | 30d | receipt → |
| 2025-06-26 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-06-26 | DGilbert Cisneros | SELL | $1K – $15K | 14d | receipt → |
| 2025-06-11 | DGilbert Cisneros | SELL | $1K – $15K | 29d | receipt → |
| 2025-06-11 | DGilbert Cisneros | SELL | $1K – $15K | 29d | receipt → |
| 2025-06-11 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 27d | receipt → |
| 2025-06-26 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 12d | receipt → |
| 2025-06-11 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 27d | receipt → |
| 2025-06-26 | DGilbert Cisneros | PARTIAL_SELL | $1K – $15K | 12d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 42d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-12 | RJefferson Shreve | SELL | $15K – $50K | 41d | receipt → |
| 2025-05-13 | DGilbert Cisneros | SELL | $1K – $15K | 27d | receipt → |
| 2025-05-13 | DGilbert Cisneros | SELL | $1K – $15K | 24d | receipt → |
| 2025-05-13 | DGilbert Cisneros | SELL | $1K – $15K | 24d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 22d | receipt → |
| 2025-04-21 | RBruce Westerman | SELL | $1K – $15K | 21d | receipt → |
“Observed gap” is the calendar distance from transaction date to filing date; only gaps over 45 days receive an apparent-delay marker.